Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Discontinuation of Riociguat on Right Heart Function in Patients With CTEPH After Combination Therapy

NCT06922240 is registered in ClinicalTrials.gov with Suqiao Yang as lead sponsor.

NCT NCT06922240
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06922240 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Discontinuation of Riociguat on Right Heart Function in Patients With CTEPH After Combination Therapy
Lead sponsor
Suqiao Yang
Phase
Phase 3
Overall status
Recruiting
Start date
March 21, 2025
Completion date
October 31, 2027
Enrollment
68 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic thromboembolic pulmonary hypertension